000 | 01558 a2200421 4500 | ||
---|---|---|---|
005 | 20250514205349.0 | ||
264 | 0 | _c20050204 | |
008 | 200502s 0 0 eng d | ||
022 | _a0091-2700 | ||
024 | 7 |
_a10.1177/0091270004269518 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGupta, Samir | |
245 | 0 | 0 |
_aPharmacokinetics/pharmacodynamics of desloratadine and fluoxetine in healthy volunteers. _h[electronic resource] |
260 |
_bJournal of clinical pharmacology _cNov 2004 |
||
300 |
_a1252-9 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAnti-Allergic Agents _xadverse effects |
650 | 0 | 4 | _aArea Under Curve |
650 | 0 | 4 |
_aCytochrome P-450 CYP2D6 _xmetabolism |
650 | 0 | 4 | _aCytochrome P-450 CYP2D6 Inhibitors |
650 | 0 | 4 | _aElectrocardiography |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFluoxetine _xadverse effects |
650 | 0 | 4 |
_aHistamine H1 Antagonists, Non-Sedating _xadverse effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLoratadine _xadverse effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aSelective Serotonin Reuptake Inhibitors _xadverse effects |
700 | 1 | _aBanfield, Christopher | |
700 | 1 | _aKantesaria, Bhavna | |
700 | 1 | _aFlannery, Brian | |
700 | 1 | _aHerron, Jerry | |
773 | 0 |
_tJournal of clinical pharmacology _gvol. 44 _gno. 11 _gp. 1252-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1177/0091270004269518 _zAvailable from publisher's website |
999 |
_c15186249 _d15186249 |